Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
24 hedge funds and large institutions have $59.6M invested in Alpine Immune Sciences Inc in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 5 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 5
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $63M → $59.6M (-$3.46M)
14% less funds holding
Funds holding: 28 → 24 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$174K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$149K |
| 3 |
DS
DRW Securities
Chicago,
Illinois
|
+$117K |
| 4 |
AWCI
Alpine Woods Capital Investors
Purchase,
New York
|
+$41.2K |
| 5 |
BlackRock
New York
|
+$29.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$269K |
| 2 |
Millennium Management
New York
|
-$110K |
| 3 |
SIM
Spark Investment Management
New York
|
-$108K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$88K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$44.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Wells Fargo
San Francisco,
California
| – | -$88K | -10,993 | Closed |
|
27
Bank of America
Charlotte,
North Carolina
| – | -$5.26K | -638 | -100% |
|
|
PWM
28
Perigon Wealth Management
San Francisco,
California
| – | -$1K | -150 | Closed |
|
29
Barclays
London,
United Kingdom
| – | -$1K | -134 | Closed |
|
ALPN Hedge Fund Activity: Q2 2018 in Review
24 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2018, worth a combined $59.6M — down 5.5% from $63M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ALPN and 1 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 9 added.
The largest buyer was Renaissance Technologies, adding an estimated $174K. The largest seller was BVF Inc, cutting an estimated $269K.
- 24 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2018, down from 28 in Q1 2018.
- Funds reported $59.6M of Alpine Immune Sciences Inc stock for Q2 2018, down 5.5% quarter-over-quarter.
- 1 fund opened new Alpine Immune Sciences Inc positions in Q2 2018 and 5 closed out, a net change of -4 holders.
- The largest Alpine Immune Sciences Inc buyer in Q2 2018 was Renaissance Technologies, an estimated $174K added.
- The largest Alpine Immune Sciences Inc seller in Q2 2018 was BVF Inc, an estimated $269K sold.
Based on aggregated 13F filings for Q2 2018.